Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr 1;7(1):56.
doi: 10.1186/1465-9921-7-56.

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test

Affiliations

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test

Inger Brock et al. Respir Res. .

Abstract

Background: Although tuberculosis (TB) is a minor problem in Denmark, severe and complicated cases occur in HIV positive. Since the new M. tuberculosis specific test for latent TB, the QuantiFERON-TB In-Tube test (QFT-IT) became available the patients in our clinic have been screened for the presence of latent TB using the QFT-IT test. We here report the results from the first patients screened.

Methods: On a routine basis the QFT-IT test was performed and the results from 590 HIV positive individuals consecutively tested are presented here. CD4 cell count and TB risk-factors were recorded from patient files.

Main findings: 27/590(4.6%) of the individuals were QFT-IT test positive, indicating the presence of latent TB infection. Among QFT-IT positive patients, 78% had risk factors such as long-term residency in a TB high endemic area (OR:5.7), known TB exposure (OR:4.9) or previous TB disease (OR:4.9). The prevalence of latent TB in these groups were 13%, 16% and 19% respectively. There was a strong correlation between low CD4 T-cell count and a low mitogen response (P < 0.001;Spearman) and more patients with low CD4 cell count had indeterminate results.

Conclusion: We found an overall prevalence of latent TB infection of 4.6% among the HIV positive individuals and a much higher prevalence of latent infection among those with a history of exposure (16%) and long term residency in a high endemic country (13%). The QFT-IT test may indeed be a useful test for HIV positive individuals, but in severely immunocompromised, the test may be impaired by T-cell anergy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IFN-γ release after stimulation of whole blood with either TB antigen (left) or Phytohaematglutinin (PHA)(mitogen) (right). All results are stratified into intervals according to the level of IFN-γ released after stimulation and the number of individuals with IFN-γ release within each interval are shown.
Figure 2
Figure 2
Study Flow Diagram for 607 HIV positive patients screened with the QFT- IT test. TB risk factors implies: prior TB diagnosis, history of TB exposure, history of long-term residency in a TB high endemic country (>25 cases per 100.000/year).
Figure 3
Figure 3
IFN-γ release (IU/mL) after stimulation of whole blood with PHA (mitogen). Results are stratified into intervals according to the CD4-cell count for each individual. The median IFN-γ values within each CD4-cell count interval are indicated with horizontal lines. Cut off for PHA response of 0.5 IU/ml is shown by a dotted line.

Similar articles

Cited by

References

    1. WHO Global tuberculosis control- surveillance, planning, financing. WHO report 2005. WHO/HTM/TB/2005. 2005. http://www.who.int/tb/publications/global_report/2005/en/
    1. Horsburgh CR., Jr Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 350(20):2060–7. doi: 10.1056/NEJMsa031667. 2004; May 13. - DOI - PubMed
    1. Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005;19(11):1113–1124. doi: 10.1097/01.aids.0000176211.08581.5a. July 22. - DOI - PubMed
    1. American Thoracic Society Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000;49(RR-6):1–51. - PubMed
    1. Lein AD, von-Reyn CF, Ravn P, Horsburg CR, Alexander LN, Andersen P. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab. 1999;6:606–609. - PMC - PubMed

Publication types

MeSH terms

Substances